This inventor holds 2 USPTO granted patents. Top assignee: The Dupont Merck Pharmaceutical Company. Active years: 1991-1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991-1992
Title: John W Blasecki: Innovator in Retroviral Treatment
Introduction
John W Blasecki is a notable inventor based in Newark, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of retroviruses. With a total of 2 patents, his work has the potential to impact the lives of many individuals affected by these viruses.
Latest Patents
Blasecki's latest patents focus on the inhibition of HIV and other retroviruses through the use of polyoxoanions. These patents disclose pharmaceutical compositions that contain polyoxoanions, along with methods for using them either alone or in combination with other compounds, such as AZT and Poly-I:C. The innovative approach also includes the disclosure of novel polyoxoanions, which could enhance treatment options for patients.
Career Highlights
Throughout his career, John W Blasecki has been associated with The DuPont Merck Pharmaceutical Company. His work there has allowed him to explore and develop groundbreaking treatments that address critical health issues related to retroviruses.
Conclusion
John W Blasecki's contributions to the field of pharmaceuticals, particularly in the treatment of retroviruses, highlight his role as an influential inventor. His innovative patents and work with The DuPont Merck Pharmaceutical Company underscore the importance of continued research and development in this vital area of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile